Patent US5194259A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5194259A Expired / Lapsed US ⏱️ 0.0 years remaining

Slimming composition based on ginkgo biloba as an alpha-2-blocker

Assignee: L'Oréal SA
•
Filing: 1991-11-27
•
Granted: 1993-03-16
•
Expires: 2011-11-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A cosmetic slimming composition for topical application to the skin contains in combination Ginkgo biloba as an alpha-2-blocker and at least one other alpha-2-blocker. This anti-cellulitis composition is capable of checking or stopping local fat accumulation and improving the esthetic appearance of the skin.

Inventors

  • 👤 Etienne Soudant
  • 👤 Jean-Francois Nadaud

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 17:01
CPC Classifications
A; A61; A61K; A61K8/00; A61K8/18; A61K8/30; A61K8/63; A61K36/00; A61K36/16; A61K45/00; A61K45/06; A61K8/96; A61K8/97; A61K8/9771; A61K8/9783; A61K8/9789; A61P; A61P17/00; A61P3/00; A61Q; A61Q19/00; A61Q19/06; A61K2800/00; A61K2800/70

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 103 words
A cosmetic slimming composition for topical application to the skin comprising in a cosmetic vehicle suitable for topical application to the skin, in combination, ginkgo biloba as an alpha-2-blocker present in an amount ranging from 0.2 to 5 weight percent based on the total weight of said composition and at least one other alpha-2-blocker selected from the group consisting of ivy present in an amount ranging from 0.01 to 15 weight percent based on the total weight of said composition and escine present in an amount ranging from 0.05 to 4 weight percent based on the total weight of said composition, or both.
Claim 2
Dependent Claim 103 words
A cosmetic slimming composition for topical application to the skin comprising in a cosmetic vehicle suitable for topical application to the skin, in combination, ginkgo biloba as an alpha-2-blocker present in an amount ranging from 0.2 to 5 weight percent based on the total weight of said composition and at least one other alpha-2-blocker selected from the group consisting of ivy present in an amount ranging from 0.01 to 15 weight percent based on the total weight of said composition and escine present in an amount ranging from 0.05 to 4 weight percent based on the total weight of said composition, or both.
Claim 3
Dependent Claim 29 words
The composition of claim 1 wherein said ginkgo biloba is present in an amount ranging from 0.05 to 2 weight percent based on the total weight of said composition.
Claim 4
Dependent Claim 28 words
The composition of claim 1 wherein said ivy is present in an amount ranging from 0.05 to 5 weight percent based on the total weight of said composition.
Claim 5
Dependent Claim 28 words
The composition of claim 1 wherein said escine is present in an amount ranging from 0.1 to 2 weight percent based on the total weight of said composition.
Claim 6
Dependent Claim 19 words
The composition of claim 1 which also contains at least one lipolytic agent acting at the level of phosphodiesterase.
Claim 7
Dependent Claim 11 words
The composition of claim 5 wherein said lipolytic agent is caffeine.
Claim 8
Dependent Claim 12 words
The composition of claim 1 which also contains at least one β-agonist.
Claim 9
Dependent Claim 16 words
The composition of claim 7 wherein said β-agonist is adrenalin or a derivative or analog thereof.
Claim 10
Dependent Claim 26 words
A cosmetic treatment for improving the esthetic appearance of a person comprising applying to the skin of said person the cosmetic slimming composition of claim 1.
Claim 11
Dependent Claim 19 words
The cosmetic treatment of claim 1 which is carried out in conjunction with a diet or an exercise program.

References Cited (Backward Citations)

US4187291A Cited
US4800080A Cited
US4684522A Cited
US4767618A Cited
EP0120165A2 Cited
US4525359A Cited
US4588724A Cited
US4795638A Cited
US4683140A Cited
US5043323A Cited
US4981688A Cited
US5080901A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-03-15 1996-09-14 1997-03-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-03-15 2000-09-14 2001-03-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-03-15 2004-09-14 2005-03-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag